Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2018-03-29 | John C. Lechleiter 37 Age: 64 37 Independent Director Since: 2013 37 Committees: Compensation, Nominating and Governance ... The table below shows compensation for James P. Hackett, who became President 26 CEO on May 19, 2017, Robert L. Shanks, who served as Executive Vice President 26 Chief Financial Officer during 2017, Mark Fields, who served as President 26 CEO from January 1 until May 19, 2017, and the three most highly compensated executive officers at the end of 2017. ... Name Fees Earned or Paid in Cash 6 Stock Awards 7 ... John C. Lechleiter 100,000 214,991 ... Total 394,389 ... Compensation Committee The Compensation Committee has reviewed and discussed the Compensation Discussion and Analysis (CD26A) with management. Based on this review and discussion, the Committee recommended to the Board of Directors that the CD26A be included in this Proxy Statement and incorporated by reference into our Annual Report on Form 10-K for the year ended December 31, 2017. |
| 2019-03-29 | John C. Lechleiter 37 Age: 65 37 Independent Director Since: 2013 37 Committees: Compensation, Nominating and Governance Director Compensation in 2018 37 John C. Lechleiter 37 Fees Earned or Paid in Cash: 100,000 37 Stock Awards: 214,990 37 Perquisites/Evaluation Vehicles: 16,853 37 Tax Reimbursement: 18,521 37 Life Insurance Premiums: 254 37 All Other Compensation: 35,628 37 Total: 350,618 |
| 2020-04-03 | John C. Lechleiter 366 3Independent Director Since: 2013 3Committees: Compensation, Nominating and Governance Director Compensation in 2019 table shows total compensation of $356,718 for John C. Lechleiter. |
| Filing Date | Source Excerpt |
|---|---|
| 2014-07-25 | Dr. Lechleiter, 60, a director since 2009, is Chairman of the Board, President, and Chief Executive Officer of Eli Lilly and Company. |
| 2015-07-27 | Dr. Lechleiter, 61, a director since 2009, is Chairman of the Board, President, and Chief Executive Officer of Eli Lilly and Company. |
| 2016-07-25 | Dr. Lechleiter, 62, a director since 2009, is Chairman of the Board, President, and Chief Executive Officer of Eli Lilly and Company. |
| 2017-07-25 | Dr. Lechleiter, 63, a director since 2009, is the former Chairman of the Board, President, and Chief Executive Officer of Eli Lilly and Company. |
| 2018-07-25 | Dr. Lechleiter was selected to serve on the Board because his operational executive experience and his knowledge of science, marketing, management, and international business allow him to provide the Board with significant contributions. |
Data sourced from SEC filings. Last updated: 2025-07-01